A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

被引：0
|
作者：
William Schelman
Sherry Morgan-Meadows
Howard Bailey
Kyle Holen
James P. Thomas
Jens Eickhoff
Heidi Brandon
Kate Oliver
Dona Alberti
George Wilding
机构：
[1] University of Wisconsin Paul P. Carbone Comprehensive Cancer Center,
[2] Southern Cancer Center,undefined
[3] The Ohio State University Comprehensive Cancer Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Gemcitabine; Patupilone; Chemotherapy; Phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：727 / 733
页数：6
相关论文
共 50 条
  • [31] Combination chemotherapy of carboplatin and gemcitabine against solid tumors: A phase I trial
    Tassinari D.
    Drudi G.
    Panzini I.
    Pasini G.
    Arcangeli V.
    Fochessati F.
    Gianni L.
    Mianulli A.M.
    Oliverio G.
    Pasquini E.
    Sartori S.
    Ravaioli A.
    International Journal of Clinical Oncology, 2001, 6 (6) : 279 - 283
  • [32] Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
    Kessler, Elizabeth R.
    Eckhardt, S. Gail
    Pitts, Todd M.
    Bradshaw-Pierce, Erica L.
    O'byrant, Cindy L.
    Messersmith, Wells A.
    Nallapreddy, Sujatha
    Weekes, Colin
    Spratlin, Jennifer
    Lieu, Christopher H.
    Kane, Madeleine A.
    Eppers, Sarah
    Freas, Elizabeth
    Leong, Stephen
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 176 - 183
  • [33] Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
    Elizabeth R. Kessler
    S. Gail Eckhardt
    Todd M. Pitts
    Erica L. Bradshaw-Pierce
    Cindy L. O’byrant
    Wells A. Messersmith
    Sujatha Nallapreddy
    Colin Weekes
    Jennifer Spratlin
    Christopher H. Lieu
    Madeleine A. Kane
    Sarah Eppers
    Elizabeth Freas
    Stephen Leong
    Investigational New Drugs, 2016, 34 : 176 - 183
  • [34] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [35] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [36] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [37] Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors
    Duran, Ignacio
    Hotte, Sebastien J.
    Hirte, Holger
    Chen, Eric X.
    MacLean, Martha
    Turner, Sandra
    Duan, Lixia
    Pond, Gregory R.
    Lathia, Chetan
    Walsh, Scott
    Wright, John J.
    Dancey, Janet
    Siu, Lillian L.
    CLINICAL CANCER RESEARCH, 2007, 13 (16) : 4849 - 4857
  • [38] A clinical phase I trial of topotecan in combination with carboplatin in patients with advanced solid tumors
    Thodtmann, R
    Kemmerich, M
    Depenbrock, H
    Heuser, A
    van Oosterom, AT
    Hanauske, AR
    ANNALS OF ONCOLOGY, 1998, 9 : 69 - 69
  • [39] Phase I of fixed-dose-rate gemcitabine in combination with bortezomib in patients with advanced solid tumors
    Luu, T. H.
    Chow, W. A.
    Lim, D.
    Koczywas, M.
    Frankle, P.
    Cristea, M.
    Somlo, G.
    Morgan, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
    William, William N., Jr.
    Lee, Joseph L.
    Shin, Dong M.
    Hong, Waun K.
    Liu, Suyu
    Lee, J. Jack
    Lippman, Scott M.
    Khuri, Fadlo R.
    Kim, Edward S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 15 - 19
12345